作者
Joshua Yukich, Peder Digre, Sara Scates, Luc Boydens, Emmanuel Obi, Nicky Moran, Allison Belemvire, Mariandrea Chamorro, Benjamin Johns, Keziah L Malm, Lena Kolyada, Ignatius Williams, Samuel Asiedu, Seydou Fomba, Jules Mihigo, Desire Boko, Baltazar Candrinho, Rodaly Muthoni, Jimmy Opigo, Catherine Maiteki-Sebuguzi, Damian Rutazaana, Josephat Shililu, Asaph Muhanguzi, Kassahun Belay, Joel Kisubi, Joselyn Annet Atuhairwe, Presley Musonda, Nduka Iwuchukwu, John Ngosa, Elizabeth Chizema, Reuben Zulu, Emmanuel Kooma, John Miller, Adam Bennett, Kyra Arnett, Kenzie Tynuv, Christelle Gogue, Joseph Wagman, Jason H Richardson, Laurence Slutsker, Molly Robertson
发表日期
2022/6/11
期刊
Malaria Journal
卷号
21
期号
1
页码范围
185
出版商
BioMed Central
简介
Background
Malaria is a major cause of morbidity and mortality globally, especially in sub-Saharan Africa. Widespread resistance to pyrethroids threatens the gains achieved by vector control. To counter resistance to pyrethroids, third-generation indoor residual spraying (3GIRS) products have been developed. This study details the results of a multi-country cost and cost-effectiveness analysis of indoor residual spraying (IRS) programmes using Actellic®300CS, a 3GIRS product with pirimiphos-methyl, in sub-Saharan Africa in 2017 added to standard malaria control interventions including insecticide-treated bed nets versus standard malaria control interventions alone.
Methods
An economic evaluation of 3GIRS using Actellic®300CS in a broad range of sub-Saharan African settings was conducted using a variety of primary data collection and evidence synthesis methods. Four IRS programmes in Ghana, Mali …
学术搜索中的文章
J Yukich, P Digre, S Scates, L Boydens, E Obi, N Moran… - Malaria Journal, 2022